Updates on COVID-19 (including visitor restrictions and mask requirements), monkeypox and flu. See Communicable Disease Updates

Sixth Annual Clinical Advances in the Diagnosis and Management of Pulmonary Hypertension

Join us October 15th in San Diego or via our live virtual stream!

Join us October 15th in San Diego or via our live virtual stream!

This CME conference is designed to educate clinicians on state-of-the-art care for pulmonary hypertension.

Conference Location

Hyatt Regency La Jolla at Aventine

3777 La Jolla Village Drive

San Diego, California 92122

Scripps Corporate Rate: 82902

Conference Details

Conference Details

Conference Overview

Conference Overview

Pulmonary hypertension (PH) is a common and widely misunderstood syndrome that results from a surprisingly large number of disease processes. It can occur at any age and the risk of developing PH increases with age and other medical conditions. Great strides have been made in the past 15 years in diagnosing and treating pulmonary arterial hypertension (PAH), so the natural history of PAH is rapidly changing. On the other hand, the more common clinical variant pulmonary venous hypertension (PVH), has been largely unaffected by medical therapy. In addition, there is often a divide between those who treat PAH and clinicians whose patients have PVH and are frustrated by the lack of effective therapy.


This conference will be unique in that it will cover all forms of pulmonary hypertension. Expert faculty will discuss the epidemiology of PH, how PH is diagnosed, and the poor outcomes associated with PH when left untreated. Clinicians will leave with a better understanding of the difference between PAH and PVH and why the difference matters. Therapies for PAH and PVH will also be discussed with reference to current clinical guidelines. Participants will return to their practice equipped with the latest evidence base and practical information to improve patient outcomes.

Educational Objectives

Educational Objectives

After attending this live activity, participants should be able to:

  • Describe the epidemiology and pathophysiology of pulmonary hypertension.
  • Determine who is at risk for pulmonary hypertension and effectively diagnose patients.
  • Recognize the difference between PAH and PVH and how this translates into therapy.
  • Outline the current approach to pulmonary hypertension treatment in the presence of related or underlying diseases.
  • Evaluate current pharmacologic and medical management strategies for patients with pulmonary hypertension.
  • Incorporate novel therapies into patient care for improved outcomes.
  • Identify when to refer patients for specialty treatment.

Accreditation and Disclosures

Accreditation and Disclosures

Physicians

Scripps Health is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

 

Scripps Health designates this live activity for a maximum of 4.5 AMA PRA Category 1 Credit(s)™. Physicians should only claim credit commensurate with the extent of their participation in the activity.

 

ABIM MOC Points

Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 4.5 Medical Knowledge MOC points in the American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.


Nurses and Nurse Practitioners

For the purpose of recertification, the American Nurses Credentialing Center accepts AMA PRA Category 1 Credit(s)™ issued by organizations accredited by the ACCME.


For the purpose of re-licensure, the California Board of Registered Nursing accepts AMA PRA Category 1 Credit(s)™ for attendance at structured learning activities offered by organizations accredited by the ACCME.


The American Academy of Nurse Practitioners Certified Program (AANPCP) and the American Association of Nurse Practitioners (AANP) accept AMA PRA Category 1 Credit(s)™ from organizations accredited by the ACCME.


Physician Assistants

NCCPA accepts AMA PRA Category 1 Credit™ from organizations accredited by ACCME or a recognized state medical society.


Pharmacists

The California Board of Pharmacy accepts as continuing professional education those courses that meet the standard of relevance to pharmacy practice and have been approved for AMA PRA Category 1 Credit(s)™.


Respiratory Therapists

For the purpose of re-licensure, the Respiratory Care Board of California accepts AMA PRA Category 1 Credit(s) for attendance at structured learning activities offered by organizations accredited by the ACCME.  

 

Commercial Support

This course may be supported, in part, by educational grants from industry. In accordance with the ACCME Standards for Integrity and Independence in Accredited Continuing Education, a complete list of commercial support received will be provided to all learners who participate in the continuing education activity. For more information: www.accme.org/standards.

 

Cultural & Linguistic Competency and Implicit Bias

This activity is designed to include curriculum addressing the topics of cultural and linguistic competency (CLC) and implicit bias (IB) in compliance with California Business and Professions (B&P) Code Section 2190. All those involved in the planning and execution of this activity have been asked to identify and discuss issues relevant to the topics being covered. In addition, a variety of resources are available that address cultural and linguistic competency and implicit bias. A resource document can be downloaded from the Conference Details section above.

Event details

Location
Hyatt Regency La Jolla at Aventine
3777 La Jolla Village Drive
San Diego, CA 92122
Get directions
Date and time

Sat, Oct 15, 2022

7 am - 1 pm